Overview

A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test

Status:
Completed
Trial end date:
2008-03-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate dose-response relationship, antipsoriatic efficacy and safety of different concentrations of topical formulations with AN2728 in subjects with psoriasis vulgaris.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate